Celltech Discovery Solutions
Includes adenocarcinoma, squamous cell carcinoma, and small-cell lung cancer lines.
Covers hormone receptor–positive, triple-negative, HER2+ breast cancer models.
Features adenocarcinoma, metastatic variants, and chemotherapy-resistant strains.
Includes ductal adenocarcinoma and resistant pancreatic tumor cell lines.
ALL, AML, CML, multiple myeloma, Hodgkin’s, non-Hodgkin’s lymphoma.
Squamous cell carcinoma and adenocarcinoma lines.
Models for endocrine and gynecological cancers.
Hard-to-find lines (e.g., lingual carcinoma, rare hematological malignancies).
Your cart is empty Continue Shopping